England Rejects Funding For Kimmtrak, Onureg & Minjuvi But Says Yes To Idefirix, Evrenzo & Verzenios

 
• By Neena Brizmohun

Immunocore’s advanced uveal melanoma drug, Kimmtrak, and Hansa’s Idefirix for increasing the chances of a successful kidney transplant are among the latest treatments that NICE has appraised regarding their cost-effectiveness.

Balance scales with capsules pills and money coins. 3d render.
NICE assesses whether drugs are cost-effective • Source: Alamy

More from United Kingdom

More from Europe